- Fondaparinux - drug2009 | First Faculty of Medicine
- Position of fondaparinux in current clinical pracitice2022 | First Faculty of Medicine, Third Faculty of Medicine
- Fondaparinux +12005 | First Faculty of Medicine
- Fondaparinux in the treatment of acute coronary syndromes2007 | First Faculty of Medicine
- Favorable coagulation profile with fondaparinux after hip surgery in elderly patients2009 | First Faculty of Medicine
- FondaparinuxPublication without faculty affiliation
- Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux the FUTURA/OASIS-82010 | First Faculty of Medicine, Third Faculty of Medicine
- Pentasacharides in the treatment of acute pulmonary embolism2012 | Second Faculty of Medicine
- Fondaparinux in the initial and long-term treatment of venous thromboembolism2015 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Anticoagulation therapy in 20152015 | First Faculty of Medicine
- Anticoagulation therapy in 20152016 | Publication without faculty affiliation
- Heparin-induced thrombocytopenia treated with fondaparinux: single center experience2020 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- New antithrombotics in the prevention of venous thromboembolia and new anti-platelet drugs2011 | Faculty of Medicine in Hradec Králové
- Fondaparinux - nové antitrombotikum +1Publication without faculty affiliation
- doplnit2011 | Faculty of Medicine in Hradec Králové
- Effective use of fondaparinux in patient with unresponsiveness to nadroparin2021 | First Faculty of Medicine
- Antithrombotic Therapy With Fondaparinux in Relation to Interventional Management Strategy in Patients With ST- and Non-ST-Segment Elevation Acute Coronary Syndromes An Individual Patient-Level Combined Analysis of OASIS 5 and 6 - randomized trials2008 | Third Faculty of Medicine
- Population pharmacokinetics-pharmacodynamics of fondaparinux in dialysis-dependent chronic kidney disease patients undergoing chronic renal replacement therapy2022 | First Faculty of Medicine, Faculty of Pharmacy in Hradec Králové
- Comparison of fondaparinux and enoxaparin in acute coronary syndromes2006 | First Faculty of Medicine, Third Faculty of Medicine
- Population pharmacokinetics-pharmacodynamics of fondaparinux in dialysis-dependent chronic kidney disease patients undergoing chronic renal replacement therapy (August, 10.1007/s00228-021-03201-1, 2021) +12021 | First Faculty of Medicine, Faculty of Pharmacy in Hradec Králové
- Sledování aktivity anti Xa po enoxaparinu a fondaparinuxuPublication without faculty affiliation
- Profylaxe fondaparinuxem u osmdesátiletých seniorů po operaci zlomenin proximálního femuruPublication without faculty affiliation
- Naše zkušenosti s fondaparinuxem u seniorů po operaci zlomenin horního konce stehenní kostiPublication without faculty affiliation
- Naše zkušenosti s fondaparinuxem u seniorů po operaci zlomenin horního konce stehenní kosti (2)Publication without faculty affiliation
- Naše zkušenosti s fondaparinuxem u seniorů po operaci zlomenin horního konce stehenní kosti (1)Publication without faculty affiliation
- Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Treated With Glycoprotein IIb/IIIa Inhibitors or Thienopyridines: Results From the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) Trial2009 | Third Faculty of Medicine
- New anticoagulants for thromboprophylaxis in patients having hip or knee replacement2010 | Faculty of Medicine in Hradec Králové